Interview with Key Opinion Leader – Benefits of using RNA-seq for clinical cancer diagnostics

Short interview with Thoas Fioretos, Professor in Clinical Genetics, Lund University, Sweden about major benefits of using RNA-seq in the clinical setting. 

• Improved diagnostics workflow using whole transcriptome RNA sequencing.
• Patient subtyping and risk stratification using RNA sequencing.
• Gene expression subtype classification models.
• Gene fusion analysis, such as finding true positives, comparison with gene fusions databases and investigation of the genetic context (i.e. in frame and out of frame).